Published in EMBO J on May 01, 1985
Polycistronic transcripts in trypanosomes and their accumulation during heat shock: evidence for a precursor role in mRNA synthesis. Mol Cell Biol (1988) 2.63
C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense. PLoS Pathog (2009) 2.22
Fexinidazole--a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness. PLoS Negl Trop Dis (2010) 2.08
Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei. Eukaryot Cell (2003) 1.94
High-efficiency clonal growth of bloodstream- and insect-form Trypanosoma brucei on agarose plates. Proc Natl Acad Sci U S A (1992) 1.81
Trypanosoma brucei: constitutive activity of the VSG and procyclin gene promoters. EMBO J (1990) 1.79
Murine Models for Trypanosoma brucei gambiense disease progression--from silent to chronic infections and early brain tropism. PLoS Negl Trop Dis (2009) 1.79
New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289. Antimicrob Agents Chemother (2009) 1.73
SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis. PLoS Negl Trop Dis (2011) 1.66
Accumulation and intracellular distribution of antitrypanosomal diamidine compounds DB75 and DB820 in African trypanosomes. Antimicrob Agents Chemother (2006) 1.57
Transient activity assays of the Trypanosoma brucei variant surface glycoprotein gene promoter: control of gene expression at the posttranscriptional level. Mol Cell Biol (1991) 1.55
Inhibitory activity of marine sponge-derived natural products against parasitic protozoa. Mar Drugs (2010) 1.52
Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies. Antimicrob Agents Chemother (2006) 1.48
Architectural organization in the interphase nucleus of the protozoan Trypanosoma brucei: location of telomeres and mini-chromosomes. EMBO J (1990) 1.44
Molecular characterization and classification of Trypanosoma spp. Venezuelan isolates based on microsatellite markers and kinetoplast maxicircle genes. Parasit Vectors (2015) 1.43
Retracted Trypanosoma brucei glycosomal glyceraldehyde-3-phosphate dehydrogenase genes are stage-regulated at the transcriptional level. EMBO J (1991) 1.42
The 3'-terminal region of the mRNAs for VSG and procyclin can confer stage specificity to gene expression in Trypanosoma brucei. EMBO J (1995) 1.34
Cultivation of clinically significant hemoflagellates. Clin Microbiol Rev (2002) 1.31
Transferrin-binding protein complex is the receptor for transferrin uptake in Trypanosoma brucei. J Cell Biol (1995) 1.30
Mechanism of Trypanosoma brucei gambiense resistance to human serum. Nature (2013) 1.28
Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness. Antimicrob Agents Chemother (2011) 1.26
Characterization of VSG gene expression site promoters and promoter-associated DNA rearrangement events. Mol Cell Biol (1991) 1.19
Organization of two invariant surface glycoproteins in the surface coat of Trypanosoma brucei. Infect Immun (1993) 1.18
Alterations in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to D,L-alpha-difluoromethylornithine. Antimicrob Agents Chemother (1997) 1.17
Trypanosome variant surface glycoprotein transfer to target membranes: a model for the pathogenesis of trypanosomiasis. Proc Natl Acad Sci U S A (1990) 1.16
Specific binding of proteins to the noncoding strand of a crucial element of the variant surface glycoprotein, procyclin, and ribosomal promoters of trypanosoma brucei. Mol Cell Biol (1995) 1.12
Bone marrow nitric oxide production and development of anemia in Trypanosoma brucei-infected mice. Infect Immun (1995) 1.12
Differential regulation of two distinct families of glucose transporter genes in Trypanosoma brucei. Mol Cell Biol (1993) 1.09
Stimuli of differentiation regulate RNA elongation in the transcription units for the major stage-specific antigens of Trypanosoma brucei. Nucleic Acids Res (1995) 1.09
Killing of trypanosomatid parasites by a modified bovine host defense peptide, BMAP-18. PLoS Negl Trop Dis (2009) 1.06
Cysteine eliminates the feeder cell requirement for cultivation of Trypanosoma brucei bloodstream forms in vitro. J Exp Med (1985) 1.05
Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late-stage central nervous system african trypanosomiasis. Antimicrob Agents Chemother (2010) 1.04
The actin gene promoter of Trypanosoma brucei. Nucleic Acids Res (1991) 1.04
Aquaporin 2 mutations in Trypanosoma brucei gambiense field isolates correlate with decreased susceptibility to pentamidine and melarsoprol. PLoS Negl Trop Dis (2013) 1.04
Bromopyrrole alkaloids as lead compounds against protozoan parasites. Mar Drugs (2010) 1.03
Inhibition of nitric oxide synthesis leads to reduced parasitemia in murine Trypanosoma brucei infection. Infect Immun (1994) 1.02
Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign. PLoS Negl Trop Dis (2012) 1.02
Synthesis and antiprotozoal activity of cationic 1,4-diphenyl-1H-1,2,3-triazoles. J Med Chem (2010) 1.00
Complete in vitro life cycle of Trypanosoma congolense: development of genetic tools. PLoS Negl Trop Dis (2010) 1.00
Quinuclidine derivatives as potential antiparasitics. Antimicrob Agents Chemother (2007) 0.99
In vitro trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitors. Antimicrob Agents Chemother (1996) 0.98
Metabolomics guides rational development of a simplified cell culture medium for drug screening against Trypanosoma brucei. Antimicrob Agents Chemother (2013) 0.97
Subcellular localization of a variable surface glycoprotein phosphatidylinositol-specific phospholipase-C in African trypanosomes. J Cell Biol (1987) 0.95
Trypanocidal activity of melamine-based nitroheterocycles. Antimicrob Agents Chemother (2004) 0.95
Antioxidant and anti-protease activities of diazepinomicin from the sponge-associated Micromonospora strain RV115. Mar Drugs (2012) 0.95
Feeder layer-free in vitro assay for screening antitrypanosomal compounds against Trypanosoma brucei brucei and T. b. evansi. Antimicrob Agents Chemother (1989) 0.95
Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis. Antimicrob Agents Chemother (2013) 0.93
2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections. Bioorg Med Chem (2010) 0.93
Exposed epitopes on a Trypanosoma equiperdum variant surface glycoprotein altered by point mutations. EMBO J (1991) 0.91
Iron-dependent regulation of transferrin receptor expression in Trypanosoma brucei. Biochem J (1999) 0.90
Isothermal microcalorimetry, a new tool to monitor drug action against Trypanosoma brucei and Plasmodium falciparum. PLoS Negl Trop Dis (2012) 0.89
Molecular and biochemical characterization of a cathepsin B-like protease family unique to Trypanosoma congolense. Eukaryot Cell (2008) 0.88
Application of a resazurin-based high-throughput screening assay for the identification and progression of new treatments for human African trypanosomiasis. Int J Parasitol Drugs Drug Resist (2012) 0.86
Bis-acridines as lead antiparasitic agents: structure-activity analysis of a discrete compound library in vitro. Antimicrob Agents Chemother (2007) 0.86
Identification of a developmentally regulated iron superoxide dismutase of Trypanosoma brucei. Biochem J (2001) 0.86
In vitro growth inhibition of bloodstream forms of Trypanosoma brucei and Trypanosoma congolense by iron chelators. Kinetoplastid Biol Dis (2006) 0.86
Immunization with recombinant actin from Trypanosoma evansi induces protective immunity against T. evansi, T. equiperdum and T. b. brucei infection. Parasitol Res (2008) 0.85
Trypanosoma vivax GM6 antigen: a candidate antigen for diagnosis of African animal trypanosomosis in cattle. PLoS One (2013) 0.85
Trypanocidal activity of the proteasome inhibitor and anti-cancer drug bortezomib. Parasit Vectors (2009) 0.84
In vivo investigations of selected diamidine compounds against Trypanosoma evansi using a mouse model. Antimicrob Agents Chemother (2009) 0.84
Trypanocidal activities of trileucine methyl vinyl sulfone proteasome inhibitors. Parasitol Res (2004) 0.83
Trypanocidal activity of salinomycin is due to sodium influx followed by cell swelling. Parasit Vectors (2013) 0.82
Active transport of L-proline in the protozoan parasite Trypanosoma brucei brucei. Biochem J (1993) 0.81
Efficient introduction of plasmid DNA into Trypanosoma brucei and transcription of a transfected chimeric gene. Proc Natl Acad Sci U S A (1987) 0.81
The animal trypanosomiases and their chemotherapy: a review. Parasitology (2016) 0.80
Agrochemicals against malaria, sleeping sickness, leishmaniasis and Chagas disease. PLoS Negl Trop Dis (2012) 0.80
Antitrypanosomal activity of some medicinal plants from Nigerian ethnomedicine. Parasitol Res (2011) 0.80
The efficacy of inhibitors involved in spermidine metabolism in Plasmodium falciparum, Anopheles stephensi and Trypanosoma evansi. Parasitol Res (2004) 0.79
Kinetic study of the plasma-membrane potential in procyclic and bloodstream forms of Trypanosoma brucei brucei using the fluorescent probe bisoxonol. Biochem J (1996) 0.79
Antiprotozoal activity of 1-phenethyl-4-aminopiperidine derivatives. Antimicrob Agents Chemother (2009) 0.79
PG12, a phospholipid analog with potent antimalarial activity, inhibits Plasmodium falciparum CTP:phosphocholine cytidylyltransferase activity. J Biol Chem (2011) 0.78
Evidence for diploidy in metacyclic forms of African trypanosomes. Proc Natl Acad Sci U S A (1989) 0.78
Anti-protozoal activity of aporphine and protoberberine alkaloids from Annickia kummeriae (Engl. & Diels) Setten & Maas (Annonaceae). BMC Complement Altern Med (2013) 0.77
Identification of plakortide E from the Caribbean sponge Plakortis halichondroides as a trypanocidal protease inhibitor using bioactivity-guided fractionation. Mar Drugs (2014) 0.77
The trypanocidal Cape buffalo serum protein is xanthine oxidase. Infect Immun (1997) 0.77
Ubiquitination of plasma membrane ectophosphatase in bloodstream forms of Trypanosoma brucei. Parasitol Res (2005) 0.76
A cultivation method for growing bloodstream forms of Trypanosoma brucei to higher cell density and for longer time. Parasitol Res (2015) 0.76
A new nonpolar N-hydroxy imidazoline lead compound with improved activity in a murine model of late-stage Trypanosoma brucei brucei infection is not cross-resistant with diamidines. Antimicrob Agents Chemother (2014) 0.76
Evaluation of the in vitro trypanocidal activity of methylated flavonoid constituents of Vitex simplicifolia leaves. BMC Complement Altern Med (2015) 0.76
Comparative genomics of drug resistance in Trypanosoma brucei rhodesiense. Cell Mol Life Sci (2016) 0.76
Infection-associated decline of cape buffalo blood catalase augments serum trypanocidal activity. Infect Immun (1999) 0.76
Efficacy of common laboratory disinfectants and heat on killing trypanosomatid parasites. Parasit Vectors (2008) 0.75
A new approach to chemotherapy: drug-induced differentiation kills African trypanosomes. Sci Rep (2016) 0.75
The establishment of in vitro culture and drug screening systems for a newly isolated strain of Trypanosoma equiperdum. Int J Parasitol Drugs Drug Resist (2017) 0.75
In vitro trypanocidal activity of macela (Achyrocline satureioides) extracts against Trypanosoma evansi. Korean J Parasitol (2014) 0.75
Combinations of Alkaloids Affecting Different Molecular Targets with the Saponin Digitonin Can Synergistically Enhance Trypanocidal Activity against Trypanosoma brucei brucei. Antimicrob Agents Chemother (2015) 0.75
In Vitro Trypanocidal Activity of Antibodies to Bacterially Expressed Trypanosoma brucei Tubulin. Iran J Parasitol (2012) 0.75
Antifungal Enantiomeric Styrylpyrones from Sanrafaelia ruffonammari and Ophrypetalum odoratum. Nat Prod Bioprospect (2014) 0.75
The Major Protein Arginine Methyltransferase in Trypanosoma brucei Functions as an Enzyme-Prozyme Complex. J Biol Chem (2016) 0.75
Comparative efficacy of different in vitro cultivation media for Trypanosoma evansi isolated from different mammalian hosts inhabiting different geographical areas of India. J Parasit Dis (2013) 0.75
In vitro activity of salinomycin and monensin derivatives against Trypanosoma brucei. Parasit Vectors (2016) 0.75
Quinolone Amides as Antitrypanosomal Lead Compounds with In Vivo Activity. Antimicrob Agents Chemother (2016) 0.75
Trypanocidal and cysteine protease inhibitory activity of isopentyl caffeate is not linked in Trypanosoma brucei. Parasitol Res (2016) 0.75
The trypanocidal effect of NO-releasing agents is not due to inhibition of the major cysteine proteinase in Trypanosoma brucei. Parasitol Res (2009) 0.75
Trypanocidal action of Lippia alba and Lippia origanoides essential oils against Trypanosoma evansi in vitro and in vivo used mice as experimental model. J Parasit Dis (2016) 0.75
Antigenic variation in trypanosomes. Nature (1978) 3.24
[Trypanosoma equiperdum: antigenic variations in experimental trypanosomiasis of rabbits]. Exp Parasitol (1977) 2.62
Identification of the trypanocidal factor in normal human serum: high density lipoprotein. Proc Natl Acad Sci U S A (1978) 1.87
African trypanosomes: cultivation of animal-infective Trypanosoma brucei in vitro. Science (1977) 1.72
Inhibition of glutathione synthesis as a chemotherapeutic strategy for trypanosomiasis. J Exp Med (1981) 1.53
An approach to the development of new drugs for African trypanosomiasis. J Exp Med (1978) 1.51
In vitro cultivation of bloodstream forms of Trypanosoma brucei, T. rhodesiense, and T. gambiense. J Protozool (1981) 1.32
Purine metabolism in the bloodstream forms of Trypanosoma gambiense and Trypanosoma rhodesiense. Biochim Biophys Acta (1982) 1.19
Stabilization and preservation of the antigenic specificity of Trypanosoma (Trypanozoon) brucei variant specific surface antigens by mild fixation techniques. Acta Trop (1977) 1.06
Absence of kinetoplast DNA in a late antigenic variant of Trypanosoma equiperdum. Mol Biochem Parasitol (1980) 1.06
Pedigrees of the Edinburgh Trypanosoma (Trypanozoon) antigenic types (ETat). Trans R Soc Trop Med Hyg (1975) 1.05
Serological cross-reactions among trypanosome variable antigen isotypes of the subgenus Trypanozoon. Ann Soc Belg Med Trop (1982) 1.02
Primary murine bone marrow cultures support continuous growth of infectious human trypanosomes. Science (1983) 1.02
[Comparative immunoelectrophoretic analysis of culture and bloodstream forms of "trypanosoma" (Trypanozoon) brucei gambiense". Demonstration of stage and antigenic type specific antigens (author's transl)]. Ann Immunol (Paris) (1975) 1.00
Growth of infective forms of Trypanosoma (T.) brucei on buffalo lung and Chinese hamster lung tissue culture cells. Acta Trop (1978) 0.95
[Trypanosoma equiperdum: antigenic variations in experimental trypanosomiasis of rabbits]. Exp Parasitol (1977) 2.62
zA map for sequence analysis of the Arabidopsis thaliana genome. Nat Genet (1999) 2.39
Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur J Immunol (1997) 1.56
DNA rearrangements and antigenic variation in Trypanosoma equiperdum: multiple expression-linked sites in independent isolates of trypanosomes expressing the same antigen. Mol Cell Biol (1983) 1.50
Genetic nomenclature for Trypanosoma and Leishmania. Mol Biochem Parasitol (1998) 1.45
Platelets play an important role in TNF-induced microvascular endothelial cell pathology. Am J Pathol (1997) 1.35
Active late-appearing variable surface antigen genes in Trypanosoma equiperdum are constructed entirely from pseudogenes. Proc Natl Acad Sci U S A (1989) 1.26
Sources cited most frequently in the experimental analysis of human behavior. Behav Anal (2000) 1.18
Heparin necrosis. An anticoagulation syndrome. JAMA (1980) 1.17
Functional and molecular characterization of a glycosomal PPi-dependent enzyme in trypanosomatids: pyruvate, phosphate dikinase. Proc Natl Acad Sci U S A (1998) 1.16
Chemical and immunological characterization of specific glycoproteins from Trypanosoma equiperdum variants. FEBS Lett (1977) 1.13
Kinetoplastid glucose transporters. Biochem J (1997) 1.13
Antigenic diversity by the recombination of pseudogenes. Genes Dev (1989) 1.12
Both TNF receptors are required for direct TNF-mediated cytotoxicity in microvascular endothelial cells. Eur J Immunol (1998) 1.11
The efficacy of pentamidine in the treatment of early-late stage Trypanosoma brucei gambiense trypanosomiasis. Am J Trop Med Hyg (1996) 1.10
Differential regulation of two distinct families of glucose transporter genes in Trypanosoma brucei. Mol Cell Biol (1993) 1.09
Pharmacokinetic properties of the trypanocidal drug melarsoprol. Chemotherapy (1993) 1.08
Absence of kinetoplast DNA in a late antigenic variant of Trypanosoma equiperdum. Mol Biochem Parasitol (1980) 1.06
A potential hexose transporter gene expressed predominantly in the bloodstream form of Trypanosoma brucei. Mol Biochem Parasitol (1992) 1.02
A diamidine-resistant Trypanosoma equiperdum clone contains a P2 purine transporter with reduced substrate affinity. Mol Biochem Parasitol (1995) 1.02
Characterization and disruption of a new Trypanosoma brucei repetitive flagellum protein, using double-stranded RNA inhibition. Mol Biochem Parasitol (2000) 1.01
The use of incomplete genes for the construction of a Trypanosoma equiperdum variant surface glycoprotein gene. EMBO J (1986) 1.01
Trypanosome glucose transporters. Mol Biochem Parasitol (1998) 1.01
Stable expression of two variable surface glycoproteins by cloned Trypanosoma equiperdum. Nature (1986) 1.00
Cannabis and sport. Br J Sports Med (2006) 1.00
Molecular characterization of the mitochondrial heat shock protein 60 gene from Trypanosoma brucei. Mol Biochem Parasitol (1995) 0.98
Posterior sagittal anorectoplasty in adults: secondary repair for persistent incontinence in patients with anorectal malformations. Dis Colon Rectum (1999) 0.98
Active control of type-I edge-localized modes with n=1 perturbation fields in the JET tokamak. Phys Rev Lett (2007) 0.97
Presence of glycerol and fatty acids in the C-terminal end of a variant surface glycoprotein from Trypanosoma equiperdum. Biochem Biophys Res Commun (1983) 0.97
Trypanosome variable surface glycoproteins: composite genes and order of expression. Genes Dev (1990) 0.97
On the role of repeated sequences 5' to variant surface glycoprotein genes in African trypanosomes. Gene (1987) 0.95
The variable surface glycoproteins of Trypanosoma equiperdum are phosphorylated. EMBO J (1982) 0.95
[Affinity of concanavalin A for "trypanosoma equiperdum": purification of the antigenic type specific glycoprotein fraction (author's transl)]. Ann Immunol (Paris) (1977) 0.95
Probing eukaryotic RNA polymerases B with monoclonal antibodies. FEBS Lett (1983) 0.94
Stability of expression-linked surface antigen gene in Trypanosoma equiperdum. Nature (1984) 0.93
How does Trypanosoma equiperdum fit into the Trypanozoon group? A cluster analysis by RAPD and multiplex-endonuclease genotyping approach. Parasitology (2003) 0.93
Characterization of Trypanozoon isolates using a repeated coding sequence and microsatellite markers. Mol Biochem Parasitol (2000) 0.92
RNA virus-like particles in pathogenic plant trypanosomatids. Mol Biochem Parasitol (1993) 0.91
In vivo and in vitro sensitivity of Trypanosoma evansi and T. equiperdum to diminazene, suramin, MelCy, quinapyramine and isometamidium. Acta Trop (1991) 0.91
Interferon-beta inhibits activated leukocyte migration through human brain microvascular endothelial cell monolayer. Lab Invest (1999) 0.91
Exposed epitopes on a Trypanosoma equiperdum variant surface glycoprotein altered by point mutations. EMBO J (1991) 0.91
Conserved organization of genes in trypanosomatids. Mol Biochem Parasitol (1998) 0.91
DNA rearrangements and antigenic variation in Trypanosoma equiperdum: expression-independent DNA rearrangements in the basic copy of a variant surface glycoprotein gene. Mol Cell Biol (1983) 0.91
Epitopes common to trypanosomes (T. cruzi, T. dionisii and T. vespertilionis (Schizotrypanum)): astrocytes and neurons. J Neuroimmunol (1987) 0.91
Re-expression of an inactivated variable surface glycoprotein gene in Trypanosoma equiperdum. Gene (1984) 0.90
Molecular characterisation of mitochondrial and cytosolic trypanothione-dependent tryparedoxin peroxidases in Trypanosoma brucei. Mol Biochem Parasitol (2001) 0.90
Complex lipids as common antigens to Trypanosoma cruzi, T. dionisii, T. vespertilionis and nervous tissue (astrocytes, neurons). Acta Trop (1987) 0.89
Trypanosoma brucei and Trypanosoma cruzi: life cycle-regulated protein tyrosine phosphatase activity. Exp Parasitol (1995) 0.89
Characterization of glucose transport and cloning of a hexose transporter gene in Trypanosoma cruzi. Proc Natl Acad Sci U S A (1994) 0.88
Purification, cloning, and characterization of an acidic ectoprotein phosphatase differentially expressed in the infectious bloodstream form of Trypanosoma brucei. J Biol Chem (2000) 0.88
Kinetoplast DNA analysis of four Trypanosoma evansi strains. Mol Biochem Parasitol (1991) 0.88
Fatal overdose of tramadol and alprazolam. Forensic Sci Int (1999) 0.87
Antigenic variation in Trypanosoma equiperdum. Res Microbiol (1992) 0.87
Immunological evidence of a common structure between Paramecium surface antigens and Trypanosoma variant surface glycoproteins. Exp Cell Res (1986) 0.86
Assessment of central nervous system involvement in gambiense trypanosomiasis: value of the cerebro-spinal white cell count. Trop Med Int Health (1998) 0.86
African trypanosome glucose transporter genes: organization and evolution of a multigene family. Mol Biol Evol (1994) 0.86
Fatal flecainide intoxication. Forensic Sci Int (1999) 0.86
Secondary structure of the variant surface glycoproteins of trypanosomes. FEBS Lett (1987) 0.86
Hexose uptake in Trypanosoma cruzi: structure-activity relationship between substrate and transporter. Biochem J (1996) 0.85
Functional expression and characterization of the Trypanosoma brucei procyclic glucose transporter, THT2. Biochem J (1995) 0.84
[Verification/validation of the performances of analytical method]. Ann Biol Clin (Paris) (2010) 0.84
Affinity chromatography using trypanocidal arsenical drugs identifies a specific interaction between glycerol-3-phosphate dehydrogenase from Trypanosoma brucei and Cymelarsan. Eur J Biochem (1999) 0.84
A novel C-terminal kinesin is essential for maintaining functional acidocalcisomes in Trypanosoma brucei. J Biol Chem (2001) 0.83
Cloning and characterization of a variant surface glycoprotein expression site from Trypanosoma equiperdum. Mol Cell Biol (1986) 0.83
Variant specific glycoproteins of Trypanosoma equiperdum: cross reacting determinants and chemical studies. Biochem Biophys Res Commun (1981) 0.83
Identification of glycosylphosphatidylinositol-specific phospholipases C in mouse brain membranes. Biochem J (1990) 0.83
Characterization of a life-cycle-stage-regulated membrane protein tyrosine phosphatase in Trypanosoma brucei. Eur J Biochem (1995) 0.83
Density-gradient separation of Schistosoma mansoni eggs. J Parasitol (1982) 0.81
Reduction of nilutamide by NO synthases: implications for the adverse effects of this nitroaromatic antiandrogen drug. Chem Res Toxicol (2003) 0.80